Evidence map›Paper›PMID 21398519›Full record

ArticleThe Journal of biological chemistry2011

Difference in stability of the N-domain underlies distinct intracellular properties of the E1064A and H1069Q mutants of copper-transporting ATPase ATP7B.

Oleg Y Dmitriev, Ashima Bhattacharjee, Sergiy Nokhrin, Eva-Maria E Uhlemann, Svetlana Lutsenko

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Epidemiology of Wilson's Disease and Pathogenic Variants of theInternational journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Genetics and epigenetic factors of Wilson disease.Annals of translational medicine · 2019
    Review
  12. Article
  13. The genetics of Wilson disease.Handbook of clinical neurology · 2017
    Review
  14. Article
  15. Review
  16. Article
  17. Modifying factors and phenotypic diversity in Wilson's disease.Annals of the New York Academy of Sciences · 2014
    Review
  18. Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  19. Intestinal expression of metal transporters in Wilson's disease.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2013
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Oleg Y DmitrievDepartment of Biochemistry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. oleg.dmitriev@usask.ca
Ashima Bhattacharjee
Sergiy Nokhrin
Eva-Maria E Uhlemann
Svetlana Lutsenko
University of Saskatchewan · CAJohns Hopkins University · US

Funding

The role of transferrin receptor 2 in iron homeostasisP01GM067166 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI KAPLAN, JACK H · 2003 to 2013
$14.6M
Molecular Mechanisms of ATP-dependent Copper TransportersR01DK071865 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI SVETLANA LUTSENKO · 2005 to 2026
$7.9M
CIHRNIDDK NIH HHS R01 DK071865NIGMS NIH HHS P01 GM067166NIGMS NIH HHS P01GM067166
6 · The paper itself

Abstract

Wilson disease (WD) is a disorder of copper metabolism caused by mutations in the Cu-transporting ATPase ATP7B. WD is characterized by significant phenotypic variability, the molecular basis of which is poorly understood. The E1064A mutation in the N-domain of ATP7B was previously shown to disrupt ATP binding. We have now determined, by NMR, the structure of the N-domain containing this mutation and compared properties of E1064A and H1069Q, another mutant with impaired ATP binding. The E1064A mutation does not change the overall fold of the N-domain. However, the position of the α1,α2-helical hairpin (α-HH) that houses Glu(1064) and His(1069) is altered. The α-HH movement produces a more open structure compared with the wild-type ATP-bound form and misaligns ATP coordinating residues, thus explaining complete loss of ATP binding. In the cell, neither the stability nor targeting of ATP7B-E1064A to the trans-Golgi network differs significantly from the wild type. This is in a contrast to the H1069Q mutation within the same α-HH, which greatly destabilizes protein both in vitro and in cells. The difference between two mutants can be linked to a lower stability of the α-HH in the H1069Q variant at the physiological temperature. We conclude that the structural stability of the N-domain rather than the loss of ATP binding plays a defining role in the ability of ATP7B to reach the trans-Golgi network, thus contributing to phenotypic variability in WD.

Indexed as

Mutation, MissenseAdenosine TriphosphatasesAdenosine TriphosphateAmino Acid SubstitutionCation Transport ProteinsCopper-Transporting ATPasesHEK293 CellsHepatolenticular DegenerationHumansProtein BindingProtein StabilityProtein Structure, TertiaryStructure-Activity Relationshiptrans-Golgi NetworkAdenosine TriphosphatasesAdenosine TriphosphateATP7B protein, humanCation Transport ProteinsCopper-Transporting ATPases

Identifiers

PMID21398519
PMCPMC3091241
OpenAlexW1987516951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.